170531 ⎘
Assays involving biological materials from specific organisms or of a specific nature Protease inhibitors
Sub-classes:COMPOSITIONS, METHODS AND USES OF ALPHA 1-ANTITRYPSIN FOR TREATMENT OF GRAFT VERSUS HOST DISEASE
#2WHOLE BLOOD CONTROL SAMPLE SYSTEMS AND METHOD OF PREPARING AND USING THE SAME
#3DETECTING SEPSIS
#4INTER-ALPHA INHIBITOR PROTEINS
#5METHODS FOR PREDICTING AND REDUCING THE RISK OF PRETERM BIRTH
#6Method for diagnosing risk for inflammatory disease through glycan profiling
#7Biomarkers for Typing Allograft Recipients
#8Methods for detection, staging, and surveillance of colorectal adenomas and carcinomas
#9Assay to measure factor Xa inhibitors
#10COMPOSITIONS AND METHODS RELATED TO THERAPEUTIC CELL SYSTEMS EXPRESSING EXOGENOUS RNA
#11DETECTING SEPSIS
#12METHODS AND MATERIALS FOR MODULATING DEUBIQUITINASES AND UBIQUITINATED POLYPEPTIDES
#13Method and kit for determining the probability that a patient will develop a severe case of dengue
#14BIOMARKERS FOR PREDICTING DEGREE OF WEIGHT LOSS IN FEMALE SUBJECTS
#15Method for measurement of peptidic degradation products of a proteolytic cascade in blood samples
#16GOLD NANOPARTICLE-BASED HOMOGENEOUS COLORIMETRIC DIAGNOSTIC ASSAY FOR THE DETECTION OF PROTEASES AND PROTEASE INHIBITORS
#17Protein biomarkers for immune assessment and prediction of transplant rejection
#18Method and kit for determining the probability that a patient will develop a severe case of dengue
#19Methods and materials for treating cancers that express reduced levels of wild-type p53 polypeptides
#20COMPOSITIONS FOR OVARIAN CANCER ASSESSMENT HAVING IMPROVED SPECIFICTY
#21METHODS AND COMPOSITIONS FOR THE DIAGNOSIS OF ALZHEIMER'S DISEASE
#22Method for measurement of peptidic degradation products of a proteolytic cascade in blood samples
#23CLOSTRIDIUM GENE
#24Methods and materials for modulating deubiquitinases and ubiquitinated polypeptides
#25Kinase and phosphatase assays
#26Compositions, methods and uses of alpha 1-antitrypsin for early intervention in bone marrow transplantation and treatment of graft versus host disease
#27SERUM PROTEOMIC FOR FINDING DIAGNOSTIC MARKERS AND FOR MONITORING THERAPEUTICAL INTERVENTION IN TREATMENT OF HEPATOCELLULAR CARCINOMA
#28Kinase and phosphatase assays
#29Methods for predicting cardiac toxicity
#30Thymic stromal lymphpoietin promoter and use therefor
#31SPECIMEN PRETREATMENT LIQUID, KIT FOR MEASURING VIRUS, AND METHOD FOR DETECTING VIRUS
#32METHOD OF IDENTIFYING COMPOUNDS THAT MODULATE CASPASE 9 ACTIVITY VIA USE OF A KOSMOTROPIC SALT
#33SUPPRESSION OF INHIBITORS
#34Nucleic acids encoding monomers of a type II serine proteinase inhibitor
#35Cancer Treatment and Cancer Treatment Efficacy Prediction by Blocking and Detecting Protease Inhibitors
#36Preparation and composition of inter-alpha inhibitor proteins from human plasma for therapeutic use
#37Nananoic acid derivatives as dipeptidyl peptidase inhibitors
#38METHOD FOR DIAGNOSING LIVER FIBROSIS
#39METHOD FOR DIAGNOSING LIVER FIBROSIS
#40IMMUNOASSAY FOR HIV PROTEASE INHIBITORS
#41Kinase and phosphatase assays
#42Proteinase inhibitor, precursor thereof and genetic sequences encoding same
#43Caspase 9 activation and uses therefor
#44Compositions and methods for preventing, treating and diagnosing diabetes
#45Methods for detecting TAFIa or TAFIai
#46Immunoassay for HIV protease inhibitors
#47Mutant proteinase-inhibitors and uses thereof
#48Immunoassay for HIV protease inhibitors
#49Isolated monomers of a type II serine proteinase inhibitor
#50Method for identification of proteins from intracellular bacteria
#51Kinase and phosphatase assays
#52Method for identification and/or diagnosis of REM sleep loss from blood samples
#53Topical and orally administered protease inhibitors and bacterial vectors for the treatment of disorders and methods of treatment
#54Topical and orally administered protease inhibitors and bacterial vectors for the treatment of disorders and methods of treatment